Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06848244 · ClinicalTrials.gov registry record · NA

Preventing Type 2 Diabetes in Black Emergent Adult

A NA study of Obesity and Type 2 Diabetes Mellitus, sponsored by University of North Carolina, Chapel Hill.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06848244 is a NA study of Obesity and Type 2 Diabetes Mellitus that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 100 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06848244, a NA study of Obesity and Type 2 Diabetes Mellitus, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Black Americans are disproportionately affected by diabetes, with nearly double the rates of type 2 diabetes mellitus (T2DM), compared to non-Hispanic White adults. Though numerous factors affect these disparities, one modifiable risk factor may be that of binge eating (BE), which increases risk for binge-eating disorder (BED), which is associated with severe obesity, and often precedes a T2DM diagnosis, beginning in childhood or adolescence. Nearly 30% of Black women with obesity report binge eating episodes. Furthermore, given that binge and overeating may disparately increase the odds of obesity in Black adults (15-fold increase vs. 6-fold increase in White adults), reducing this behavior will be critical to prevent continued disparities in T2DM diagnosis. Given that Black women have the highest rates of obesity in the nation (57%), report disparate rates of weight gain between young adulthood and mid adulthood, and report disparate rates of emotional eating in adolescence, which is a risk factor for BE, one pathway to reducing disparities in T2DM risk in Black women may be to reduce binge eating and prevent weight gain in emerging adulthood (ages 18-25).

Interventions

  • BEHAVIORAL Diabetes Prevention Program (DPP)
  • BEHAVIORAL Appetite Awareness Training (AAT)

Study Locations (1)

North Carolina

  • UNC-Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-06-30
Est. Completion 2030-12
Phase NA

What the Registry Record Tells You About NCT06848244

The ClinicalTrials.gov registry entry for NCT06848244 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Diabetes Prevention Program (DPP) is the first listed.

NCT06848244 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06848244 about?

NCT06848244 is a clinical study titled "Preventing Type 2 Diabetes in Black Emergent Adult". Black Americans are disproportionately affected by diabetes, with nearly double the rates of type 2 diabetes mellitus (T2DM), compared to non-Hispanic White adults. Though numerous factors affect these disparities, one modifiable risk factor may be that of binge eating (BE), which increases risk for...

What is the current status of trial NCT06848244?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-06-30. Estimated completion is 2030-12.

What conditions does trial NCT06848244 study?

This clinical trial studies the following conditions: Obesity, Type 2 Diabetes Mellitus, Binge-Eating Disorder, Binge Eating.

What interventions are being tested in trial NCT06848244?

The interventions under investigation include: Diabetes Prevention Program (DPP) (BEHAVIORAL), Appetite Awareness Training (AAT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06848244?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06848244 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.